牙源性角化囊肿SMO基因突变的检测
研究收集2012年9月至2017年6月北京大学口腔医院口腔颌面外科的30例OKC患者(10例痣样基底细胞癌综合征性OKC、20例散发性OKC),分离衬里上皮和纤维间质后行Sanger测序,检出3个SMO基因突变,其中前2个为新突变,2例散发性OKC不伴PTCH1突变;除PTCH1突变外OKC还存在SMO基因突变,可能与OKC发病机制有关。
要点
- 在1例综合征性OKC中检出SMO c.2081C>G(p.P694R)突变。
- 在2例散发性OKC中分别检出c.907C>T(p.L303F)和c.1247_1248delinsAA(p.G416E)突变。
- 前2个突变为未报道过的新突变,2例散发性OKC均不伴PTCH1突变。
核心结论
- 除PTCH1突变外,OKC还存在SMO基因突变,可能与OKC的发病机制有关。
- 靶向音猬因子通路的小分子抑制剂可为OKC的临床治疗提供思路。
研究设计与样本
- 收集2012年9月至2017年6月就诊于北京大学口腔医学院·口腔医院口腔颌面外科的OKC患者。
- 10例为痣样基底细胞癌综合征性OKC(女性4例,男性6例),20例为散发性OKC(女性7例,男性13例)。
- 采集病变组织,分离衬里上皮和纤维间质,采用Sanger测序法分别检测上皮与间质DNA中SMO突变情况。
主要发现
- 检测发现3个SMO基因突变位点:1例综合征性OKC携带c.2081C>G(p.P694R)突变。
- 2例散发性OKC分别携带c.907C>T(p.L303F)突变和c.1247_1248delinsAA(p.G416E)突变。
- 前2例突变为未被报道过的SMO新突变。
- 2例散发性OKC均不伴PTCH1突变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To detect the SMO mutations in odontogenic keratocyst (OKC) and to explore the mechanism behind. Methods: Patients with OKC who received treatment in the Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology,Peking University, from September 2012 to June 2017 were enrolled. OKC samples from 10 patients diagnosed as naevoid basal cell carcinoma syndrome (NBCCS)-related OKC (4 females and 6 males) and 20 patients diagnosed as sporadic OKC (7 females and 13 males) were collected. Genomic DNAs were extracted from fibrous capsules and epithelial lining respectively. SMO mutations were detected and analyzed by Sanger sequencing. Results: Three SMO mutations were found in one NBCCS-associated OKC who carrying c.2081C>G (p.P694R) mutation) and two sporadic OKC who carrying c.907C>T (p.L303F) mutation and c.1247_1248delinsAA (p.G416E), respectively), among which the first two mutations were novel mutations that had not been reported before. Besides, two mutations in sporadic OKC were not paired with PTCH1 mutations. Conclusions: In addition to PTCH1 gene mutations, SMO gene mutations also exist in OKC which might be related to the development of OKC. 目的: 检测牙源性角化囊肿(odontogenic keratocyst,OKC)是否存在SMO基因突变,进一步完善对OKC发病机制的认识。 方法: 收集2012年9月至2017年6月就诊于北京大学口腔医学院·口腔医院口腔颌面外科的OKC患者,10例为痣样基底细胞癌综合征性OKC(女性4例,男性6例),20例为散发性OKC(女性7例,男性13例)。采集患者的病变组织,分离衬里上皮和纤维间质,采用Sanger测序法分别检测上皮与间质DNA中SMO突变情况。 结果: 检测发现3个SMO基因突变位点,即1例综合征性OKC携带c. 2081C>G(p.P694R)突变,2例散发性OKC分别携带c. 907C>T(p.L303F)突变和c. 1247_1248delinsAA(p.G416E)突变,前2例突变为未被报道过的SMO新突变,且2例散发性OKC均不伴PTCH1突变。 结论: 除PTCH1突变外,OKC还存在SMO基因突变,可能与OKC的发病机制有关,靶向音猬因子通路的小分子抑制剂可为OKC的临床治疗提供思路。.
引用
- Zhai JM, Wang S, Hong YY, et al. [Detection of SMO gene mutations in odontogenic keratocyst]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2022. PMID: 35152650. doi:10.3760/cma.j.cn112144-20211214-00547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。